US Stock MarketDetailed Quotes

TMDX TransMedics

Watchlist
  • 76.018
  • +1.898+2.56%
Trading Mar 28 10:18 ET
2.49BMarket Cap-98724P/E (TTM)

About TransMedics Company

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Company Profile

SymbolTMDX
Company NameTransMedics
Listing Date05/02/2019
Issue Price16.00
Founded1998
CEODr. Waleed Hassanein, M.D.
MarketNASDAQ
Employees584
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Minuteman Road,Suite 302
CityAndover
ProvinceMassachusetts
CountryUnited States of America
Zip Code01810
Phone1-978-552-0900

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Waleed Hassanein, M.D.
  • President, Chief Executive Officer and Director
  • 7.37M
  • Stephen Gordon
  • Chief Financial Officer, Treasurer and Secretary
  • 1.97M
  • Dr. Tamer Khayal, M.D.
  • Chief Commercial Officer
  • 1.99M
  • Dr. Miriam Provost, PhD
  • Vice President, Global Regulatory Affairs
  • 953.54K
  • Laura Damme
  • Vice President, Clinical Affairs
  • 851.66K
  • Nick Corcoran
  • Senior Vice President, Supply Chain and Operations
  • --
  • James R. Tobin
  • Chairman of the Board
  • 284.96K
  • Edwin M. Kania, Jr.
  • Independent Director
  • 244.14K
  • Merilee Raines
  • Independent Director
  • 283.86K
  • Thomas J. Gunderson
  • Independent Director
  • 247.46K
  • Stephanie Lovell
  • Independent Director
  • 533.41K
  • Edward M. Basile
  • Independent Director
  • 251.29K
  • Dr. David Weill, M.D.
  • Independent Director
  • 242.46K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg